Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Primary Therapy for Hodgkin's Lymphoma
NCT00188149Phase 4Unknown
- Sponsor
- University Hospital Carl Gustav Carus
- Start
- May 2000
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxorubicin, bleomycin, vinblastine, dacarbazine, cyclophosphamide in Hodgkin lymphoma (HL), sponsored by University Hospital Carl Gustav Carus. Status: unknown.
02
Drugs
doxorubicinbleomycinvinblastinedacarbazinecyclophosphamide
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00188149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188149.